✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Evotec SE

Common Name
Evotec
Country
Germany
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4,467
Ticker
EVT
Exchange
XETRA
Description
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two k...

Evotec's GHG Emissions Data Preview

In 2025, Evotec completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Evotec has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Location-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metricb
0000000
Limited Data Preview
You are viewing a limited preview of Evotec’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=EVT&reporting_period=2025"

Verified Sources Behind Evotec’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Evotec’s data sources below and access millions more through our Disclosure Search.

a. Evotec's Integrated Report 2025
b. Evotec's Sustainability Report 2024

Insights into Evotec's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Evotec amounted to 29,300 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Evotec decreased by 17.03%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Evotec's Scope 1 Emissions Over Time

2021202220232024202505 k10 k15 k20 ktCO2e-10%-8%-14%-19%
  • Total Scope 1
  • Year-over-Year Change

What are Evotec's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Evotec were 11,179 metric tons of CO₂ equivalent (tCO₂e).a

Has Evotec reduced its Scope 1 emissions over time?

Since 2021, Evotec's Scope 1 emissions have decreased by 41.34%, reflecting a declining long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2024), Evotec's Scope 1 emissions decreased by 18.73%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Evotec's Scope 2 emissions?

In 2025, Evotec reported Scope 2 greenhouse gas (GHG) emissions of 2,583 tCO₂e using the market-based method and 18,121 tCO₂e using the location-based method.a

Has Evotec reduced its Scope 2 emissions over time?

Since 2021, Evotec's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have remained relatively stable, indicating that Evotec's emissions have plateaued with no significant change in its energy consumption footprint.a

Compared to the previous year (2024), Evotec's Scope 2 emissions (Location-Based) fell by 15.94% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Evotec use for Scope 2 reporting?

In 2025, Evotec reported its Scope 2 emissions using the market-based method and using the location-based method.a

Evotec's Scope 2 Emissions Over Time

2021202220232024202505.5 k11 k16.5 k22 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Evotec's Value Chain Emissions

In 2025, Evotec reported 126,108 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Evotec includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Evotec's Scope 3 Emissions Over Time

20212022202320242025070 k140 k210 k280 ktCO2e+22%+34%-34%-30%
  • Total Scope 3
  • Year-over-Year Change

What are Evotec's Scope 3 emissions?

In 2025, Evotec reported total Scope 3 emissions of 126,108 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 99.95% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.05% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Evotec reduced its Scope 3 emissions over time?

Since 2021, Evotec's Scope 3 emissions have decreased by 24.52%, reflecting a declining long-term trend in Scope 3 emissions over time.a

Compared to the previous year (2024), Evotec's Scope 3 emissions decreased by 30.04%, highlighting the company's efforts to lower indirect emissions from its value chain.a

What categories of Scope 3 emissions does Evotec disclose?

In 2025, Evotec reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Evotec's Scope 3 emissions?

In 2025, the largest contributors to Evotec's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 99,392 tCO₂e (78.81%)
  • Capital Goods (Cat. 2): 16,838 tCO₂e (13.35%)
  • Fuel- and Energy-Related Services (Cat. 3): 3,810 tCO₂e (3.02%)

Evotec's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(78.8%)Capital Goods(Cat. 2)(13.4%)Fuel- andEnergy-RelatedServices (Cat. 3)(3.0%)

Insights into Evotec’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Evotec reported Scope 1 greenhouse gas (GHG) emissions of 11,179 tCO₂e and total revenues of USD 927 millions. This translates into an emissions intensity of 12.06 tCO₂e per millions USD.a

Evotec's Scope 1 Emissions Intensity Compared to Peers

1005005,00050,000200,000Scope 1 Emissions (tCO2e)1002001,0002,0005,000Revenues (Millions of USD)PCADNVetoquinolYear: 2024Scope 1: 7,159 tCO2eRevenue: $M 561Scope 1 Intensity: 12.76 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MMega LifesciencesYear: 2023Scope 1: 1,809 tCO2eRevenue: $M 455Scope 1 Intensity: 3.97 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MGrape King BioYear: 2024Scope 1: 6,559 tCO2eRevenue: $M 341Scope 1 Intensity: 19.25 tCO2e/$MWockhardtYear: 2025Scope 1: 11,404 tCO2eRevenue: $M 341Scope 1 Intensity: 33.43 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 630Scope 1 Intensity: 4.89 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MLaboratorios Farmaceuticos ROVIYear: 2024Scope 1: 9,525 tCO2eRevenue: $M 795Scope 1 Intensity: 11.99 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 364Scope 1 Intensity: 148.75 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MCCChina TCMYear: 2024Scope 1: 104,425 tCO2eRevenue: $M 2,262Scope 1 Intensity: 46.16 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MAAApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MAspen Pharmacare HoldingsYear: 2025Scope 1: 32,776 tCO2eRevenue: $M 2,450Scope 1 Intensity: 13.38 tCO2e/$MHyperaYear: 2023Scope 1: 28,386 tCO2eRevenue: $M 1,632Scope 1 Intensity: 17.40 tCO2e/$MEvotecYear: 2025Scope 1: 11,179 tCO2eRevenue: $M 927Scope 1 Intensity: 12.06 tCO2e/$M

How does Evotec's GHG emissions intensity compare to its peers?

In 2025, Evotec reported a Scope 1 emissions intensity of 12.06 tCO₂e per millions USD. Compared to the peer group median of 19.77, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Evotec rank on GHG emissions intensity within its industry?

In 2025, Evotec ranked 9 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Evotec is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Evotec's Total Carbon Footprint

In 2025, Evotec reported a total carbon footprint of 155,408 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 27.91% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Evotec's total carbon footprint was Scope 3 emissions, accounting for 81.15% of the company's total carbon footprint, followed by Scope 2 emissions at 11.66%.a

Want Full Access to Evotec's GHG Emissions Dataset?
Start 30-Day Free Trial